You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH):捷門生物獲首筆財政撥款資金80萬元
格隆匯 12-07 18:42

格隆匯12月7日丨海利生物(603718.SH)公佈,根據上海市發展和改革委員會、上海市經濟和信息化委員會、上海市商務委員會、上海市財務局《關於下達2020年第二批上海市服務業發展引導資金計劃的通知》,公司全資子公司捷門生物申報的“捷門體外診斷試劑(IVD)定製開發服務平台建設”項目列入2020年第二批上海市服務業發展引導資金支持項目,通過驗收後可獲得200萬元引導資金支持,同時區級根據《引導資金辦法》要求按照不低於1:1的比例安排配套資金。捷門生物於2020年12月4日獲首筆財政撥款資金80萬元。

截止本公告日,公司及子公司前12個月內收到與資產相關的政府補助累計172萬元,佔公司2019年度經審計的歸屬於上市公司股東的淨資產的0.16%;收到收益相關的政府補助累計為305.68萬元,佔公司2019年度經審計的歸屬於上市公司股東的淨利潤的25.16%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account